Blindness can be an incredibly devastating impairment, affecting practically every single aspect of one’s life. However, scientists have found a way to restore the sight of select cases of blindness via surgery. Specifically, the researchers are able to restore the sight of patients who became legally blind after a traumatic head injury.
Head trauma is an escalating medical issue in the United States, with over 2.5 million cases recorded by the Center for Diseases Control in 2010, Futurism reports. Of those millions of patients that suffer head trauma, every single one was at risk of developing a case of blindness, or at least some level of vision impairment.
The discovery was made thanks to the collaboration of three universities, namely; St. Louis’ Washington University School of Medicine, Wayne State University’s Kresge Eye Institute, and India’s L.V. Prasad Eye Institute. The group published their findings in the journal Ophthalmology.
With the participation of 20 legally blind patients, the researchers used vitrectomy, which is a type of surgery used to treat Terson syndrome. This is a hemorrhage case that’s typically caused by head trauma. Some of the patients suffered Terson syndrome in both eyes, which proved extremely useful during the study.
Once the surgery is done, it took only one month for the patients to experience a noticeable improvement in their vision, with some going from 20/1290 vision to 20/40, Business Insider reports. After several months passed, practically all of the participants had their vision restored to a perfect 20/20.
Even more astonishing is the fact that some of the patients were already legally blind before experiencing head trauma. After going through the procedure, their vision improved significantly.
Finally, the researchers learned that waiting longer for the head trauma to heal before undergoing the surgery did not seem to have any effects on the results. This is an important and surprising discovery since it means that victims of head trauma won’t have to worry about permanently losing their vision if they wait for months or even years.


Tabletop particle accelerator could transform medicine and materials science
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Neuralink Expands Brain Implant Trials with 12 Global Patients
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions 



